and Mass Spectrometry
    Directions

SANDMAN
Upcoming Speakers

Simple Sequential Incubation Method to Deconvolute Compicated Drug Metabolism

presented by

Hai-Zhi Bu
Pfizer - La Jolla, CA

January 12, 2006

The Scripps Research Institute, W.M. Keck Foundation Amphitheater


Background:

Education:


  • Ph.D. in Bioanalytical Chemistry, Concordia University, Montreal Canada (10/97)

  • MSc in Analytical Chemistry, Nanjing University, Nanjing, China (07/87)

  • BSc in Chemistry, Huaibei Coal Normal University, Huaibei, China


Work Experience:

  • Senior Principal Scientist, Department of Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research and Development, San Diego, California (10/04)

  • Research Scientist II, Department of Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research and Development, San Diego, California (06/01 - 09/04)

  • Staff Scientist (Study Director), Department of Metabolic Chemistry, Covance Laboratories, Madison, Wisconsin (08/99 - 06/01)

  • Research Scientist, Department of Pharmacokinetics and Drug Metabolism, SynPhar Laboratories, Edmonton, Alberta, Canada (05/97 - 07/99)

  • Associate Director, Department of Analytical Chemistry, Beijing Institute of Pharmacology and Toxicology, Beijing, China (07/87-12/93)


Has over 50 publications.

Abstract:

Capravirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV type 1, undergoes extensive oxygenations to numerous sequential metabolites in humans. Since several possible oxygenation pathways may be involved in the formation and/or sequential metabolism of a single metabolite, it is very difficult or even impossible to determine the definitive pathways and their relative contributions to the overall metabolism of capravirine using conventional approaches. For this reason, a human liver microsome-based sequential incubation method has been developed to deconvolute the complicated sequential metabolism of capravirine. Briefly, the method includes three fundamental steps: 1) 30-min primary incubation of [14C]capravirine, 2) isolation of [14C]metabolites from the primary incubate, and 3) 30-min sequential incubation of each isolated [14C]metabolite supplemented with an ongoing (30 min) microsomal incubation with non-labeled capravirine. Based on the extent of both the disappearance of the isolated precursor [14C]metabolites and the formation of sequential [14C]metabolites, definitive oxygenation pathways of capravirine were assigned. In addition, the percent contribution of a precursor metabolite to the formation of each of its sequential metabolites (called sequential contribution) and the percent contribution of a sequential metabolite formed from each of its precursor metabolites (called precursor contribution) were determined. An advantage of this system is that the sequential metabolism of each isolated [14C]metabolite can be monitored selectively by radioactivity in the presence of all relevant metabolic components (i.e., non-labeled parent and its other metabolites). This methodology should be applicable to mechanistic studies of other compounds involving complicated sequential metabolic reactions when radiolabeled materials are available.

Go to Upcoming Speakers